Analyst Recommendations

Barclays analyst issues UNDERWEIGHT recommendation for PAA on February 9, 2026 10:24AM ET. The previous analyst recommendation was Underweight.PAA was trading at $19.4 at issue of the analyst...

February 9, 2026   PAA 0.26%

Barclays analyst issues UNDERWEIGHT recommendation for ITW on February 9, 2026 10:19AM ET. The previous analyst recommendation was Underweight.ITW was trading at $293.57 at issue of the analyst...

February 9, 2026   ITW -1.88%

Barclays analyst issues OVERWEIGHT recommendation for NVT on February 9, 2026 10:21AM ET. The previous analyst recommendation was Overweight.NVT was trading at $112.64 at issue of the analyst...

February 9, 2026   NVT -7.33%

Barclays analyst issues UNDERWEIGHT recommendation for PAGP on February 9, 2026 10:24AM ET. The previous analyst recommendation was Underweight.PAGP was trading at $20.71 at issue of the analyst...

February 9, 2026   PAGP 0.35%

Barclays analyst issues OVERWEIGHT recommendation for CG on February 9, 2026 10:26AM ET. The previous analyst recommendation was Overweight.CG was trading at $58.71 at issue of the analyst...

February 9, 2026   CG -1.43%

Barclays analyst issues UNDERWEIGHT recommendation for VRTS on February 9, 2026 10:29AM ET. The previous analyst recommendation was Underweight.VRTS was trading at $140.29 at issue of the analyst...

February 9, 2026   VRTS -0.70%

Barclays analyst issues OVERWEIGHT recommendation for RRX on February 9, 2026 10:25AM ET. The previous analyst recommendation was Overweight.RRX was trading at $211.8 at issue of the analyst...

February 9, 2026   RRX -3.31%

BTIG analyst issues BUY recommendation for STNE on February 9, 2026 10:32AM ET. STNE was trading at $17.08 at issue of the analyst recommendation.The overall analyst consensus :...

February 9, 2026   STNE -19.08%

Bernstein analyst issues UNDERPERFORM recommendation for VLVOF on February 9, 2026 10:53AM ET. VLVOF was trading at $3.345 at issue of the analyst recommendation.The overall analyst consensus :...

February 9, 2026   STNE -19.08%

Citigroup analyst issues OUTPERFORM recommendation for GENI on February 9, 2026 10:41AM ET. The previous analyst recommendation was Outperform.GENI was trading at $6.09 at issue of the analyst...

February 9, 2026   GENI 1.81%